225430 — KMPharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapSucker Stock

Annual cashflow statement for KMPharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-902	471	-220	-3,925	-1,320
Depreciation
Amortisation
Non-Cash Items	602	258	1,365	3,103	598
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,107	-907	-248	-645	884
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-701	909	2,267	-93.3	1,446
Capital Expenditures	-16,323	-3,737	-2,365	-10	-113
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	3,524	807	-5,693	-5,081	-5.89
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-12,799	-2,930	-8,058	-5,091	-119
Financing Cash Flow Items	8.15	185	10	-86	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	11,516	7,048	2,195	3,501	-821
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1,983	5,027	-3,596	-1,684	506